Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis

Aim: To determine the levels of chondroitin sulphate (CS) WF6 epitope, recognized by WF6 monoclonal antibody, in gingival crevicular fluid (GCF) from different stages of periodontal disease and healthy periodontium, and to correlate those levels with clinical parameters. Material and Methods: GCF sa...

全面介紹

Saved in:
書目詳細資料
Main Authors: Khongkhunthian S., Srimueang N., Krisanaprakornkit S., Pattanaporn K., Ong-Chai S., Kongtawelert P.
格式: Article
語言:English
出版: 2014
在線閱讀:http://www.scopus.com/inward/record.url?eid=2-s2.0-51749107033&partnerID=40&md5=972f75fca40119e2304bfebc25f88d1d
http://www.ncbi.nlm.nih.gov/pubmed/18727658
http://cmuir.cmu.ac.th/handle/6653943832/1025
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Chiang Mai University
語言: English
id th-cmuir.6653943832-1025
record_format dspace
spelling th-cmuir.6653943832-10252014-08-29T09:17:37Z Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis Khongkhunthian S. Srimueang N. Krisanaprakornkit S. Pattanaporn K. Ong-Chai S. Kongtawelert P. Aim: To determine the levels of chondroitin sulphate (CS) WF6 epitope, recognized by WF6 monoclonal antibody, in gingival crevicular fluid (GCF) from different stages of periodontal disease and healthy periodontium, and to correlate those levels with clinical parameters. Material and Methods: GCF samples, collected from 389 sites, were analysed for the WF6 epitope levels by the competitive enzyme-linked immunosorbent assay. Results: The median WF6 epitope level was significantly higher in chronic periodontitis sites (n=185) than in healthy and gingivitis sites (n=204) (p<0.001), whereas the median levels did not significantly differ between healthy (n=65) and gingivitis sites (n=139). The median level in severe periodontitis sites (n=60) was significantly higher than that in moderate periodontitis sites (n=63) (p=0.019). Similarly, the median level in moderate periodontitis sites was significantly higher than that in slight periodontitis sites (n=62) (p=0.001). The WF6 epitope levels significantly correlated with probing depth (r=0.777, p=0.001) and loss of clinical attachment level (r=0.814, p=0.001). Conclusion: Elevated CS WF6 epitope levels in GCF are associated with severity of periodontitis. The WF6 antibody may therefore be clinically applied to monitor disease severity and progression. © 2008 Blackwell Munksgaard. 2014-08-29T09:17:37Z 2014-08-29T09:17:37Z 2008 Article 03036979 10.1111/j.1600-051X.2008.01312.x 18727658 JCPED http://www.scopus.com/inward/record.url?eid=2-s2.0-51749107033&partnerID=40&md5=972f75fca40119e2304bfebc25f88d1d http://www.ncbi.nlm.nih.gov/pubmed/18727658 http://cmuir.cmu.ac.th/handle/6653943832/1025 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Aim: To determine the levels of chondroitin sulphate (CS) WF6 epitope, recognized by WF6 monoclonal antibody, in gingival crevicular fluid (GCF) from different stages of periodontal disease and healthy periodontium, and to correlate those levels with clinical parameters. Material and Methods: GCF samples, collected from 389 sites, were analysed for the WF6 epitope levels by the competitive enzyme-linked immunosorbent assay. Results: The median WF6 epitope level was significantly higher in chronic periodontitis sites (n=185) than in healthy and gingivitis sites (n=204) (p<0.001), whereas the median levels did not significantly differ between healthy (n=65) and gingivitis sites (n=139). The median level in severe periodontitis sites (n=60) was significantly higher than that in moderate periodontitis sites (n=63) (p=0.019). Similarly, the median level in moderate periodontitis sites was significantly higher than that in slight periodontitis sites (n=62) (p=0.001). The WF6 epitope levels significantly correlated with probing depth (r=0.777, p=0.001) and loss of clinical attachment level (r=0.814, p=0.001). Conclusion: Elevated CS WF6 epitope levels in GCF are associated with severity of periodontitis. The WF6 antibody may therefore be clinically applied to monitor disease severity and progression. © 2008 Blackwell Munksgaard.
format Article
author Khongkhunthian S.
Srimueang N.
Krisanaprakornkit S.
Pattanaporn K.
Ong-Chai S.
Kongtawelert P.
spellingShingle Khongkhunthian S.
Srimueang N.
Krisanaprakornkit S.
Pattanaporn K.
Ong-Chai S.
Kongtawelert P.
Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis
author_facet Khongkhunthian S.
Srimueang N.
Krisanaprakornkit S.
Pattanaporn K.
Ong-Chai S.
Kongtawelert P.
author_sort Khongkhunthian S.
title Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis
title_short Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis
title_full Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis
title_fullStr Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis
title_full_unstemmed Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis
title_sort raised chondroitin sulphate wf6 epitope levels in gingival crevicular fluid in chronic periodontitis
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-51749107033&partnerID=40&md5=972f75fca40119e2304bfebc25f88d1d
http://www.ncbi.nlm.nih.gov/pubmed/18727658
http://cmuir.cmu.ac.th/handle/6653943832/1025
_version_ 1681419579351367680